| Pharmaceutical laws and regulations in Iran: An overview P Zaboli, A Hashemi-Meshkini, M Varmaghani, H Gholami, I Vazirian, ... Journal of research in pharmacy practice 5 (3), 155-161, 2016 | 47 | 2016 |
| Pharmacists remuneration models in Iran and selected countries: a comparative study A Hashemi-Meshkini, K Keshavarz, S Nikfar, I Vazirian, A Kebriaeezadeh Iranian Journal of Pharmaceutical Research: IJPR 12 (4), 995, 2013 | 18 | 2013 |
| Financial perspective of private pharmacies in Tehran (Iran); is it a lucrative business? K Keshavarz, A Kebriaeezadeh, A Hashemi Meshkini, S Nikfar, I Mirian, ... DARU Journal of Pharmaceutical Sciences 20 (62), 2012 | 18 | 2012 |
| Linagliptin versus sitagliptin in patients with type 2 diabetes mellitus: a network meta-analysis of randomized clinical trials K Keshavarz, F Lotfi, E Sanati, M Salesi, A Hashemi-Meshkini, M Jafari, ... DARU Journal of Pharmaceutical Sciences 25, 1-11, 2017 | 17 | 2017 |
| Is Taurolidine-citrate an effective and cost-effective hemodialysis catheter lock solution? A systematic review and cost-effectiveness analysis Z Kavosi, MS Khorrami, K Keshavarz, A Jafari, AH Meshkini, HR Safaei, ... Medical journal of the Islamic Republic of Iran 30, 347, 2016 | 17 | 2016 |
| Detecting diseases in medical prescriptions using data mining tools and combining techniques M Teimouri, F Farzadfar, MS Alamdari, A Hashemi-Meshkini, PA Alamdari, ... Iranian Journal of Pharmaceutical Research: IJPR 15 (Suppl), 113, 2016 | 17 | 2016 |
| Comparison of two data mining techniques in labeling diagnosis to Iranian pharmacy claim dataset: artificial neural network (ANN) versus decision tree model E Rezaei-Darzi, F Farzadfar, A Hashemi-Meshkini, I Navidi, M Mahmoudi, ... Archives of Iranian medicine 17 (12), 0-0, 2014 | 17 | 2014 |
| Evaluation of productivity in Iranian pharmaceutical companies: A DEA-based Malmquist approach and panel data analysis M Varmaghani, AH Meshkini, F Farzadfar, M Yousefi, S Yaghoubifard, ... Journal of Research in Pharmacy Practice 4 (2), 51-56, 2015 | 15 | 2015 |
| Cost-Effectiveness Analysis of Tocilizumab in Comparison with Infliximab in Iranian Rheumatoid Arthritis Patients with Inadequate Response to tDMARDs: A Multistage Markov Model A Hashemi-Meshkini, S Nikfar, E Glaser, A Jamshidi, SA Hosseini VALUE IN HEALTH REGIONAL ISSUES 9, 42-48, 2016 | 13 | 2016 |
| An overview to pharmaceutical financing in Iran M Varmaghani, A Hashemi-Meshkini, A Abdollahiasl, E Heidari, HS Zekri, ... Journal of Pharmacoeconomics and Pharmaceutical Management 2 (1/2), 45-49, 2016 | 12 | 2016 |
| Cost-effectiveness analysis review of exemestane in the treatment of primary and advanced breast cancer A Hashemi-Meshkini, K Keshavarz, Z Gharibnaseri, M Kheirandish, ... Archives of Medical Science 9 (3), 472-478, 2013 | 12 | 2013 |
| A cost-utility and cost-effectiveness analysis of different oral antiviral medications in patients with HBeAg-negative chronic hepatitis B in Iran: an economic microsimulation … K Keshavarz, A Kebriaeezadeh, SM Alavian, AA Sari, MR Hemami, F Lotfi, ... Hepatitis Monthly 16 (9), 2016 | 11 | 2016 |
| Developing a patient satisfaction questionnaire for services provided in Iranian community pharmacies S Yaghoubifard, A Rashidian, A Kebriaeezadeh, A Sheidaei, ... Journal of Research in Pharmacy Practice 5 (2), 106-115, 2016 | 10 | 2016 |
| A systematic cost-effectiveness analysis of pregabalin in the management of fibromyalgia: an Iranian experience K Keshavarz, A Hashemi-Meshkini, Z Gharibnaseri, S Nikfar, ... Archives of Medical Science 9 (6), 961-967, 2013 | 9 | 2013 |
| Assessment of the vaccine industry in Iran in context of accession to WTO: a survey study A Hashemi Meshkini, A Kebriaeezadeh, R Dinarvand, S Nikfar, ... DARU Journal of Pharmaceutical Sciences 20, 19, 2012 | 9 | 2012 |
| Pegylated versus non-pegylated interferon beta 1a in patients with relapsing-remitting multiple sclerosis: A cost-effectiveness analysis A Hashemi-Meshkini, HS Zekri, H Karimi-Yazdi, P Zaboli, MA Sahraian, ... Iranian journal of neurology 17 (3), 123, 2018 | 7 | 2018 |
| Assessment of geographic accessibility to pharmacy in Qom, Iran: a geographic information system analysis AH Meshkini, A Kebriaeezadeh, MR Janghorban, K Keshavarz, S Nikfar Thrita 3 (1), 2014 | 7 | 2014 |
| Social accounting matrix and the effects of economic reform on health price index and household expenditures: Evidence from Iran K Keshavarz, B Najafi, Y Andayesh, A Rezapour, M Abolhallaj, ... Medical journal of the Islamic Republic of Iran 31, 68, 2017 | 6 | 2017 |
| making the public health and industrial objectives balanced; the big challenge of Iran’s food and drug organization A Hashemi-Meshkini Iranian journal of public health 43 (5), 693, 2014 | 6 | 2014 |
| Cost-effectiveness analysis of adding low dose ribavirin to peginterferon alfa-2a for treatment of chronic hepatitis C infected thalassemia major patients in iran A Mehrazmay, SM Alavian, M Moradi-Lakeh, MM Payam, ... Hepatitis Monthly 13 (9), 2013 | 5 | 2013 |
Shekoufeh NikfarProfessor of Pharmacoeconomics, Tehran University of Medical Sciences (TUMS), IranVerified email at tums.ac.ir
